Skip to main content
Clinical Trials/NCT06264128
NCT06264128CompletedNot Applicable

The Effect on Subjective Comfort of a Device Providing Positive Airway Pressure (PAP) Drops During Inspiration (TPAP) Compared to Continuous Positive Airway Pressure (CPAP) in Obstructive Sleep Apnea Patients

SleepRes Inc.2 sites in 1 country150 target enrollmentStarted: March 8, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
150
Locations
2
Primary Endpoint
CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 2+2 cmH2O

Study Overview

Brief Summary

TheraPAP is a prototype device (with full documented electrical and isolation safety) being developed by SleepRes for the treatment of obstructive sleep apnea (OSA) that can deliver either standard CPAP at a set pressure or what is called TPAP . TPAP is a pressure control algorithm that lowers the pressure from the set pressure at the beginning of inspiration and does not return the pressure to the full set level until about halfway through expiration. The present study, TheraPAP Comfort, aims at assessing whether TPAP improves patient comfort vs. CPAP during supine wakefulness.

Detailed Description

The TheraPAP Comfort Study is an in-office study to assess comfort of TPAP vs. CPAP in CPAP-naïve patients with OSA during supine wakefulness. Patients will be recruited after routine outpatient visits. They will be asked to breath normally for approximately 1 minute in supine wakefulness while being administered background CPAP (at 9 or 13 cmH2O) or TPAP at various pressure drops. TPAP drops will be administered in a paired comparison before or/and after each corresponding CPAP level, according to a randomized design. Eventually, 6 one-to-one comparisons (TPAP vs. corresponding background CPAP or TPAP vs. TPAP) will be made, 3 per each randomized order. As an example, CPAP 9 will be compared to TPAP 1/1 cmH2O drops; CPAP 9 will be compared to TPAP 2/2 cmH2O drops; and TPAP 1/1 cmH2O drops will be compared to TPAP 2/2 cmH2O drops in a random sequence.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Masking Description

There is no specific intent to mask although participants will be naive to CPAP-type therapy, but they will be able to feel the difference.

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 - 70 age range
  • AHI (apnea/hypopnea index) > 10 on a previous HST (Home Sleep Test)
  • CPAP-naive participants
  • BMI (Body Mass Index) >= 18 kg/m^2

Exclusion Criteria

  • Current clinically significant sleep disorder other than OSA (Obstructive Sleep Apnea) of a severity that would interfere with study participation or interpretability of data (including central sleep apnea, per central AHI > 5 events/h).
  • Any chronic lung diseases.
  • Chronic oxygen therapy.
  • A serious illness or infection in the past 30 days as determined by investigator.
  • Patients with hypoglossal nerve stimulation implant.
  • Any non-previously mentioned vulnerable population.
  • Any condition that in the investigator's opinion would present an unreasonable risk to the participant, or which would interfere with their participation in the study or confound study interpretation.

Arms & Interventions

CPAP v TPAP

Experimental

Participants will compare CPAP to 2 different levels of TPAP, then will compare 2 levels of TPAP against each other by breathing on each pair of therapies for a minute or so, then deciding which is more comfortable or if they are equivalent.

Intervention: TPAP (Device)

CPAP v TPAP

Experimental

Participants will compare CPAP to 2 different levels of TPAP, then will compare 2 levels of TPAP against each other by breathing on each pair of therapies for a minute or so, then deciding which is more comfortable or if they are equivalent.

Intervention: CPAP (Device)

Outcomes

Primary Outcomes

CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 2+2 cmH2O

Time Frame: All tests conducted in a 20 minute time frame on awake supine patients.

Compare the comfort level of CPAP at 9 cmH2O against TPAP dropped by 2+2 cmH2O

CPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 2+3 cmH2O

Time Frame: All tests conducted in a 20 minute time frame on awake supine patients.

Compare the comfort level of CPAP at 13 cmH2O against TPAP dropped by 2+3 cmH2O

Secondary Outcomes

  • CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 1+2 cmH2O(All tests conducted in a 20 minute time frame on awake supine patients.)
  • CPAP v TPAP Patient Preference at 9 cmH2O Baseline Pressure, TPAP Drop 1+1 cmH2O(All tests conducted in a 20 minute time frame on awake supine patients.)
  • CPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 2+2 cmH2O(All tests conducted in a 20 minute time frame on awake supine patients.)
  • CPAP v TPAP Patient Preference at 13 cmH2O Baseline Pressure, TPAP Drop 1+2 cmH2O(All tests conducted in a 20 minute time frame on awake supine patients.)

Investigators

Sponsor
SleepRes Inc.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials